Post Profile






Theranos, 23andMe and Zenefits: Why Medical Startups are Still Struggling

Innovative medical companies with the potential to transform the country's healthcare system are itching to take advantage of Silicon Valley's startup incubators. But are the healthcare system and government regulators ready for them? We examine three "unicorns" that shook up the healthcare market -- and almost lost everything in the process.
read more

share
See more about: Silicon Valley

Related Posts


500 Startups Launches New Silicon Valley Incubator

Technology : Gigaom

Dave McClure's 500 Startups has invested in nearly 100 young companies since being launched last summer. Now it's looking to help them grow with an incubator program that will give them Silicon Valley work space, design and distribu...

Zenefits’s Regulatory Headaches Are All Too Common in Silicon Valley

Technology : Tech - WSJ.com

Silicon Valley has a healthy distaste for regulators preventing them from disrupting old-line industries, but government officials are giving many startups a run for their money.

Regulators warn testing startup Theranos over lab conditions

Technology : SFGate: Tech News

WASHINGTON (AP) — Federal regulators have issued a warning to blood-testing startup Theranos, saying some of the Silicon Valley company's testing procedures do not meet standards designed to protect patients. Inspectors for the Cent...

McClure Finds Innovative Start-ups Outside the U.S.

Technology : The Goods

The Silicon Valley incubator 500 Startups opens its arms to 33 new early-stage Internet companies, more than half from outside the U.S. Silicon Valley incubator 500 Startups has a fresh batch of start-up teams for its accelerator pr...

Silicon Valley, Far From Defeated, Is Simply Stuck

Medical / Healthcare IT : Chilmark Research

Earlier this month, Zenefits joined Theranos and 23andMe on the list of Silicon Valley startups to run afoul of regulators. Some commentators refer to the situation at large as Silicon Valley’s Waterloo. The headline is certainly ca...

Comments


Copyright © 2016 Regator, LLC